A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence

Condition:   Keloid Interventions:   Drug: STP705;   Other: Placebo Sponsor:   Sirnaomics Not yet recruiting

Source: ClinicalTrials.gov - April 14, 2021 Category: Research Source Type: clinical trials